Trabectedin Supply API 99%Min ecteinascidin 743 CAS 114899-77-3 Raw Material Powder CAS NO.114899-77-3
- FOB Price: USD: 0.02-0.03 /Gram Get Latest Price
- Min.Order: 1 Gram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
Top(1-1000)GramTop(1000-2000)Gram
- Product Details
Keywords
- ecteinascidin 743
- Trabectedin
- Trabectedin (Ecteinascidin 743)
Quick Details
- ProName: Trabectedin Supply API 99%Min ecteinas...
- CasNo: 114899-77-3
- Molecular Formula: C39H43N3O11S
- Appearance: White powder
- Application: Trabectedin is an alkylating agent ind...
- DeliveryTime: 3-7days
- PackAge: bag or barrel or drum
- Port: Shanghai or Shenzhen or Qingdao
- ProductionCapacity: 6000 Metric Ton/Day
- Purity: 99%+
- Storage: Store at room temperature
- Transportation: by express or air or sea
- LimitNum: 1 Gram
- Moisture Content: <0.001%
- Impurity: <0.001%
- Assay: 99%+
- Shelf Life: 2 years
- Appearance: White Powder
Superiority
English name: ecteinascidin 743
CAS number: 114899-77-3
Molecular formula: C39H43N3O11S
Molecular weight: 761.84
Melting point:>143°C(dec.)
Specific rotation: D25+114°(c=0.1inmethanol)
Density: 1.55±0.1g/cm3(20ºC760Torr)
Storage conditions: -20°C Freezer, Under inert atmosphere
Solubility: Chloroform(Slightly), Methanol(Slightly)
Acidity coefficient: (pKa) 9.73±0.40 (Predicted)
Form:Solid
Color:Light Yellow to Yellow
Trabectedin is an alkylating agent indicated for patients with unresectable or metastatic liposarcoma or leiomyosarcoma receiving a previous anthracycline-containing regimen.
On October 23, 2015, the U.S. FDA approved the marketing of Trabectedin, a drug of Janssen, a subsidiary of Johnson & Johnson, under the priority approval route, with the trade name Yondelis. For the treatment of patients with unresectable or metastatic liposarcoma and leiomyosarcoma who have received chemotherapy containing an anthracycline. Trabectedin is an alkylating agent and belongs to the cytotoxic class of drugs. In 2007, EMEA approved it for the first time in Europe for the treatment of advanced soft tissue sarcoma. It was later approved in Europe and Canada to treat recurrent ovarian cancer; the manufacturers are the Spanish biotech company Zeltia and the US Johnson & Johnson (JohnsonandJohnson).
Details
Wuhan Kanal Technology Co., Ltd. founded in 2010,it is a large manufacturer of fine Pharmaceutical& Chemical & Cosmetic materials that integrates R&D, production and sales together. Our Kanal company is established under the support of the Wuhan city government, so Kanal has large advantages in enterprise credit, finance security, product quality control, and cargo export.Kanal locates in the national new materials industry park of Wuhan city and is awarded the title of high-tech corporation.
Wuhan Kanal has its own R&D and development laboratory. We Kanal set up a R&D team with rich experience and strong technical strength, most of the practitioners have more than ten years' experience and technology in organic synthesis development. It owns almost 15 acre and more than 280 workers.
An ISO 9001 & GMP qualified company, we are mainly specialized in producing high quality but low price Pharmaceutical intermediates, APIs and other fine chemicals & cosmetics products which related to human and animals medicines as well as additives in gas &oil field, almost half of the goods are for exporting. What's more, we provide the OEM (customize) manufactures, if you can't find materials from the world, then tell us, we will research and produce in our high-tech equipmented laboratory. We are dedicated to satisfying our customers with our products and services.
1. We has 11 years' exporting experience in active pharmaceutical ingredient products.
Our professional and thoughtful after-sales service eliminates your worries.
2.We can provide you with ten thousands of products of different levels.
3. We offer convenient one-station purchasing service.
(1)Any inquiries will be replied within 12 hours.
(2)Dedication to quality, supply & service.
(3)Strictly on selecting raw materials.
(4)Reasonable & competitive price, fast lead time.
Our company is based on the optical valley biological city,making full use of the park policy advantages, focusing on the research and development of biological medicine.
The pharmaceutical intermediates are mainly applied to anti-cancer, anti-depression, cardiovascular, diabetes and other new medicine. The chemical intermediates mainly refer to heterocyclics and OLED intermediates.Our factory produce new fine chemical materials which are mainly used in water treatment, bactericidal and anti-corrosion, dyes, electronic materials and other industry fields.
Wuhan Kanal has export & import license, and hazard chemical sales license. The products are exported to America, Brazil, South Korea, Japan, Taiwan, Malaysia, Thailand, Indonesia, Europe union and other countries or regions.
Under rich experiences and excellent international reputation, the company becomes a quite influential enterprise in China's API field. Wuhan Kanal sincerely look forward to establishing long good cooperation with our customers from all over the world.